TheStreet.com TV Recap: Vaccines Give Merck Booster Shot
11/02/07 - 02:50 PM EDT
Merck is (MRK Quote) winning big with vaccines, Jim Cramer said on TheStreet.com TV's Wall Street Confidential Web video Friday.
Cramer said the company decided to get into vaccines when everyone said there was no money in vaccines. That thinking turned out to be wrong. Becton Dickinson (BDX Quote) and Cepheid (CPHD Quote) also are doing well with vaccines, Cramer said. Gardasil, the human papillomavirus vaccine from Merck, is going to be huge, Cramer and stockpickr.com's James Altucher agreed. It's going from about $300 million to $4 billion in revenue over the next year, and that's just one vaccine, he said. Plus, now they're doing late-stage trials on a hepatitis-B vaccine. "I think if you want a solid 15%, maybe 20% a year for a long time, Merck is a great bet," Altucher said.Cramer & Altucher: Give Vaccines a Shot |




